HDT

Connecticut State Department of Education Selects Varsity Tutors for State’s High-Dosage Tutoring Program

Retrieved on: 
Tuesday, August 1, 2023
Other Education, State, Local, Public Policy, Government, Primary, Secondary, Education, Varsity, School, Learning, ALEKS, Carnegie Learning, Connecticut State Department of Education, Student, Curriculum, HDT, USA High School Clay Target League, Mathematics, Tutoring, II, III, NYSE, Nerd

Varsity Tutors , a Nerdy (NYSE: NRDY) company and the leading platform for live online tutoring, has been chosen by the Connecticut State Department of Education (CSDE) as an approved tutoring provider for the state’s 2023/2024 High-Dosage Tutoring (HDT) Program.

Key Points: 
  • Varsity Tutors , a Nerdy (NYSE: NRDY) company and the leading platform for live online tutoring, has been chosen by the Connecticut State Department of Education (CSDE) as an approved tutoring provider for the state’s 2023/2024 High-Dosage Tutoring (HDT) Program.
  • This new initiative is specifically designed to address math learning gaps among students in grades 6-9 across the state.
  • Varsity Tutors for Schools offers evidence-based, high-impact tutoring programs to over 230 school districts nationwide.
  • For more information about Varsity Tutors for Schools, visit: https://www.varsitytutors.com/school-solutions
    To fill out an application for the High-Dosage Tutoring Program, please visit: https://sdect.co1.qualtrics.com/jfe/form/SV_bDjpyssv6DcHdau

A. Duie Pyle Recognized by Heavy Duty Trucking and Inbound Logistics for Sustainability Efforts

Retrieved on: 
Tuesday, July 25, 2023
Green supply chain management, Workforce, China National Heavy Duty Truck Group, HDT, Transport, Supply, Investment, Carbon, Airline, Renewable energy

WEST CHESTER, Pa., July 25, 2023 (GLOBE NEWSWIRE) -- A. Duie Pyle (Pyle), the premier provider of asset and non-asset-based supply chain solutions, today announces it has been named both a 2023 Green Supply Chain Partner by Inbound Logistics and a Top Green Fleet award winner by Heavy Duty Trucking (HDT).

Key Points: 
  • WEST CHESTER, Pa., July 25, 2023 (GLOBE NEWSWIRE) -- A. Duie Pyle (Pyle), the premier provider of asset and non-asset-based supply chain solutions, today announces it has been named both a 2023 Green Supply Chain Partner by Inbound Logistics and a Top Green Fleet award winner by Heavy Duty Trucking (HDT).
  • These awards acknowledge Pyle's commitment to implementing environmentally conscious practices across its fleet and facilities.
  • This is the sixth time that Pyle has been recognized as a Top Green Fleet, and it is the fifth time that it has been named a Green Supply Chain Partner.
  • Pyle's sustainability efforts extend beyond its fleet to include green practices in its facilities, such as operating a 100% solar-powered warehouse and transitioning to electric forklifts.

Connecticut State Department of Education Selects FEV Tutor for State's New High-Dosage Tutoring Program

Retrieved on: 
Tuesday, June 27, 2023
Learning, Connecticut State Department of Education, Student, Classification, Brigadier General David H. Stem Award, HDT, Digital Promise, Annenberg Institute at Brown University, Research, ESSA, School, Certification, FEV, Mathematics, Tutoring

WOBURN, Mass., June 27, 2023 /PRNewswire-PRWeb/ -- The Connecticut State Department of Education (CSDE) has selected FEV Tutor as an approved tutoring service in the state's new Connecticut High-Dosage Tutoring (HDT) Program. The HDT program is a new state initiative that aims to accelerate mathematics recovery for priority students in grades six through nine during the 2023-24 academic year. School districts that successfully apply to the program will receive a brief list of vetted and approved tutor providers, including FEV Tutor, as well as grant funds for implementing tutoring services.

Key Points: 
  • WOBURN, Mass., June 27, 2023 /PRNewswire-PRWeb/ -- The Connecticut State Department of Education (CSDE) has selected FEV Tutor as an approved tutoring service in the state's new Connecticut High-Dosage Tutoring (HDT) Program.
  • The HDT program is a new state initiative that aims to accelerate mathematics recovery for priority students in grades six through nine during the 2023-24 academic year.
  • School districts that successfully apply to the program will receive a brief list of vetted and approved tutor providers, including FEV Tutor, as well as grant funds for implementing tutoring services.
  • Since 2010, FEV Tutor's targeted high-impact tutoring intervention has focused on accelerating learning outcomes for the hardest to reach low-performing students.

Kite’s Yescarta® CAR T-cell Therapy Demonstrates Significantly Longer Overall Survival Versus Standard of Care as Initial Treatment of Relapsed/Refractory Large B-cell Lymphoma

Retrieved on: 
Monday, June 5, 2023
Oncology, Health, Hospitals, Clinical Trials, Pharmaceutical, Biotechnology, Neutropenia, The New England Journal of Medicine, Arm, Associate professor, FACP, Survival, Aes, OS, Drug, HDT, Clinical Lymphoma, Myeloma & Leukemia, Multimedia, SOC, Doctor of Philosophy, PFS, B-cell lymphoma, MS, MD Anderson Cancer Center, CAR, Progression-free survival, ASCT, Patient, Standard of care, Leukopenia, University, Anemia, EFS, Ageing, SVP, Abstract, Death, Society, Pharmaceutical industry, Axicabtagene ciloleucel, MD

Yescarta is the first treatment in nearly 30 years to demonstrate a significant improvement in survival in this patient population.

Key Points: 
  • Yescarta is the first treatment in nearly 30 years to demonstrate a significant improvement in survival in this patient population.
  • SOC therapy for this patient population has historically been a multi-step process expected to end with stem-cell transplant.
  • Median OS was longer with Yescarta versus SOC (not reached versus 31.1 months, respectively) and 48-month OS estimates were higher with Yescarta (54.6% versus 46.0%, respectively).
  • “Overall survival is the gold standard in cancer treatment and confirms Yescarta’s place as a treatment of curative intent for patients with relapsed/refractory large B-cell lymphoma,” said Frank Neumann, MD, PhD, SVP, Kite’s Global Head of Clinical Development.

Geotab Intelligent Transportation Systems introduces Stop Analytics for safer and sustainable road networks

Retrieved on: 
Tuesday, April 4, 2023
Bangladesh Technical Education Board, Real, Sales management, HDT, Movement, Metropolitan planning organization, Metropolitan, ITS, Dots, Benchmarking, Safety, Retail, Altitude, Transport, Geotab

TORONTO, April 4, 2023 /PRNewswire/ - Geotab Intelligent Transportation Systems (ITS) , a Geotab business unit providing governments with actionable, real-world insights to improve their transportation networks, today announced the launch of Stop Analytics, a powerful data analytics module that offers aggregate commercial vehicle parking insights.

Key Points: 
  • TORONTO, April 4, 2023 /PRNewswire/ - Geotab Intelligent Transportation Systems (ITS) , a Geotab business unit providing governments with actionable, real-world insights to improve their transportation networks, today announced the launch of Stop Analytics, a powerful data analytics module that offers aggregate commercial vehicle parking insights.
  • "We're excited to offer our customers Stop Analytics, which provides valuable insights into aggregate commercial vehicle parking activity and patterns," said Nate Veeh, Senior Business Development Manager, at Geotab Intelligent Transportation Systems.
  • Stop Analytics is the latest module available on the Geotab ITS Altitude platform,  providing valuable insights for commercial vehicle parking management.
  • For more information on Stop Analytics and the Geotab Altitude platform, visit: https://its.geotab.com/altitude/stop-analytics/

HDT Global names Kevin McSweeney President and CEO

Retrieved on: 
Friday, March 24, 2023
HDT, Griffon Corporation, Security, Retirement, Engineering, Growth, Maritime safety, Rochester Telephone Corporation, Lockheed Martin, Management

SOLON, Ohio, March 24, 2023 /PRNewswire/ -- HDT Global (HDT), announced today the appointment of Kevin McSweeney as President and CEO.

Key Points: 
  • SOLON, Ohio, March 24, 2023 /PRNewswire/ -- HDT Global (HDT), announced today the appointment of Kevin McSweeney as President and CEO.
  • "I'm very excited to have Kevin join us at HDT," stated Vince Buffa, Executive Chairman of the Board, HDT Global.
  • Mr. McSweeney comes to HDT from Telephonics Corporation, where he progressed through leadership roles including Vice President and General Manager of the Radar Systems Division, Executive Vice President responsible for all programs, business development and engineering and finally President and CEO.
  • HDT is poised for significant growth and I'm excited to be a part of the next chapter of their story."

Kite’s Yescarta® CAR T-cell Therapy Demonstrates a Statistically Significant Improvement in Overall Survival for Initial Treatment of Relapsed/Refractory Large B-cell Lymphoma

Retrieved on: 
Tuesday, March 21, 2023
Oncology, Health, Hospitals, Clinical Trials, Pharmaceutical, Biotechnology, OS, HDT, SOC, CAR, ASCT, Standard of care, Patient, SPA, EFS, FDA, Death, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Pharmaceutical industry, Agency

Kite, a Gilead Company (Nasdaq: GILD), today announced the primary overall survival (OS) analysis results of the Phase 3 ZUMA-7 study.

Key Points: 
  • Kite, a Gilead Company (Nasdaq: GILD), today announced the primary overall survival (OS) analysis results of the Phase 3 ZUMA-7 study.
  • The results showed a statistically significant improvement for Yescarta in OS versus historical treatment, which was the standard of care (SOC) in a curative setting for nearly 30 years, for initial treatment of adult patients with relapsed/refractory large B-cell lymphoma (R/R LBCL) within 12 months of completion of first-line therapy.
  • Historical SOC is a multi-step process involving platinum-based salvage combination chemoimmunotherapy regimen followed by high-dose therapy (HDT) and stem cell transplant (ASCT) in those who respond to salvage chemotherapy.
  • These findings will be presented in full later this year at an upcoming scientific meeting.

Dana's Spicer Electrified Zero-8™ e-Axles Recognized by Heavy Duty Trucking as a Top 20 Product for 2023

Retrieved on: 
Thursday, March 2, 2023
NYSE, HDT, EV, Editorial, Maintenance, China National Heavy Duty Truck Group, Motion system, Drive, Exhibition, Rail transport

MAUMEE, Ohio, March 2, 2023 /PRNewswire/ -- Dana Incorporated (NYSE: DAN) announced today that it has been honored with Heavy Duty Trucking (HDT) magazine's 2023 Top 20 Products Award for its Spicer Electrified Zero-8™ e-Axles.

Key Points: 
  • MAUMEE, Ohio, March 2, 2023 /PRNewswire/ -- Dana Incorporated (NYSE: DAN) announced today that it has been honored with Heavy Duty Trucking (HDT) magazine's 2023 Top 20 Products Award for its Spicer Electrified Zero-8™ e-Axles.
  • The family of single and tandem e-Axles are designed for a wide variety of Class 7 and 8 applications.
  • "This distinction highlights our commitment to providing our customers with the best purpose-built, zero-emission solutions as the commercial-vehicle segment continues to progress to fully electrified platforms."
  • HDT announced the 2023 Top 20 Products at this year's Technology and Maintenance Council's Annual Meeting & Transportation Technology Exhibition.

Netradyne’s Driver•iHubX® Awarded 2023 Top 20 Products by Heavy Duty Trucking

Retrieved on: 
Wednesday, March 1, 2023
Software, Hardware, Fleet Management, Data Management, Technology, Automotive, Artificial Intelligence, Trucking, Audio, Video, Automotive Manufacturing, Transport, Manufacturing, Safety, American Trucking Associations, Software as a service, Editorial, Artificial intelligence, A.I, HDT, China National Heavy Duty Truck Group, Maintenance, GPIO, VH1 Top 20 Video Countdown, Video game, Airline

and edge computing solutions focused on safety and driver coaching for commercial fleets, today announced the editors of Heavy Duty Trucking have named Driver•iHubX an HDT 2023 Top 20 Product, honoring the best new products introduced to the trucking industry in 2022.

Key Points: 
  • and edge computing solutions focused on safety and driver coaching for commercial fleets, today announced the editors of Heavy Duty Trucking have named Driver•iHubX an HDT 2023 Top 20 Product, honoring the best new products introduced to the trucking industry in 2022.
  • “We’re extremely honored that Driver•iHubX is recognized as a 2023 HDT Top 20 Product Award,” commented Avneesh Agrawal, CEO, and Co-Founder at Netradyne.
  • “By including fleet managers in determining the Top 20 Products award, we provide our audience a list of products that have the potential to address pain points and help them succeed in a fast-changing and competitive industry.”
    The full list of HDT’s 2023 Top 20 Products appears in the January/February print issue of Heavy Duty Trucking and on its website, www.truckinginfo.com .
  • Awards are presented in individual ceremonies at winners’ booths during the American Trucking Associations’ Technology & Maintenance Council annual meeting and exposition.

Angiocrine Bioscience Announces Poster Presentation of AB-205 Trial Data during the Annual Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR

Retrieved on: 
Monday, February 13, 2023
Regenerative Medicine Advanced Therapy, HDT, AB-205, Regenerative medicine, Hospital, Lymphoma, Safety, California Institute for Regenerative Medicine, CIRM, Efficacy, Center for International Blood and Marrow Transplant Research, Food, SAN, SOC, Society, Transplant, US Foods, MD, Pharmaceutical industry, Angiocrine growth factors

AB-205 is an intravenous investigational engineered cell therapy product being developed for multiple indications.

Key Points: 
  • AB-205 is an intravenous investigational engineered cell therapy product being developed for multiple indications.
  • "Our investigators and Angiocrine are honored to be selected by ASTCT & CIBMTR to present at its annual meeting this February," commented Paul Finnegan, MD, Angiocrine CEO.
  • "We look forward to Dr. Michael Scordo's presentation on the trial design of our AB-205 Phase 3 multi-center study (E-CELERATE)."
  • Additionally, the California Institute for Regenerative Medicine (CIRM) has approved investing $15M in this Phase 3 registration study.